HCPLive
DECEMBER 14, 2023
These results highlight the potential of preventing increasing CKD burden and of preventing subsequent cardiovascular conditions, especially given current rates of obesity among adolescents.
DAIC
JANUARY 8, 2025
a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD) and other diseases, hasannounced that the U.S. Subjects will be at least 18 years old, with a BMI 27 kg/m 2 , and the trial will be conducted across approximately 40 sites.
European Journal of Heart Failure
NOVEMBER 26, 2024
BMI, body mass index; eGFR, estimated glomerular filtration rate; NYHA, New York Heart Association. Discontinuation occurred early and was more common in patients with advanced kidney disease, hyperkalaemia, lack of follow-up in specialty care, more severe heart failure, comorbidities, and markers of sociodemographic frailty.
Frontiers in Cardiovascular Medicine
DECEMBER 12, 2024
Physical activity (PA), body mass index (BMI), and blood glucose were associated with aTRH (all p-values<0.05), while diet, nicotine exposure, sleep, and blood lipids were not significantly associated with aTRH. Compared to subjects with low CVH, participants with moderate and high CVH exhibited lower risks of 47% and 76%, respectively.
Circulation
NOVEMBER 11, 2024
17.4]) and was also more likely to have diabetes mellitus, hyperlipidemia, chronic lung disease, chronic kidney disease, chronic liver disease, BMI ≥ 25, anemia, metastatic cancer, and atrial fibrillation. The hemophilia cohort was slightly older (63.2[16.8]
Stroke Journal
JANUARY 30, 2025
Propensity score-matched analysis (PSM) (1:1) was performed on age, gender, BMI, hypertension, diabetes mellitus, chronic kidney disease, hemoglobin level, LDL level, left ventricular ejection fraction and various drugs including beta blockers, ACEi and ARBi. Both groups were followed for 12 months.
Stroke Journal
JANUARY 30, 2025
Propensity score-matched analysis (PSM) (1:1) was performed with matching for age, gender, race, BMI, hypertension, diabetes mellitus, chronic kidney disease, hemoglobin level, low-density lipid (LDL) level, left ventricular ejection fraction, and various drugs including ACEi, ARBi, ARNI, beta-blockers, and diuretics.
Expert insights. Personalized for you.
105 
Let's personalize your content